| Financial Year |
March 31 2023 |
| Monetary Funds |
16,524,440,253.86 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,772,625.00 |
| Accounts Receivable |
14,223,048,191.48 |
| Advances to Suppliers |
19,745,212,834.32 |
| Other Receivables |
50,270,275.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
17,055,240.81 |
| Inventories |
17,419,316,445.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,004,017,170.99 |
| Total Current Assets |
73,653,471,904.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
14,153,202,162.95 |
| Investment Properties |
171,517,876.88 |
| Fixed Assetes |
252,410,177,444.25 |
| Under-construction Projects |
47,996,797,409.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,206,468,676.47 |
| R&D expenses |
5,167,512,963.91 |
| Goodwill |
419,242,673.32 |
| Long-Term Deferred and Prepaid Expenses |
1,662,301,102.03 |
| Deferred Income Tax Assets |
2,443,530,905.42 |
| Other Non-Current Assets |
7,802,376,450.04 |
| Sub-Total of Non-Current Assets |
339,038,063,170.81 |
| Total Assets |
412,691,535,075.45 |
| Short-Term Loans |
14,261,248,819.15 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,048,227,848.05 |
| Accounts Payable |
22,758,210,449.10 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
64,295,042.94 |
| Taxes Payable |
1,891,368,985.22 |
| Interest Payable |
-- |
| Dividend Payable |
2,694,952,797.93 |
| Other payables |
5,792,082,514.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,567,606,761.81 |
| Other Current Liabilities |
1,984,282,020.32 |
| Sub-Total of Current Liabilities |
76,369,437,790.51 |
| Long-term Loans |
160,481,783,005.33 |
| Bonds Payable |
4,492,100,114.38 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,133,120,973.36 |
| Deferred Income Tax Liabilities |
1,397,301,801.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
175,415,209,242.42 |
| Total Liabilities |
251,784,647,032.93 |
| Paid-In Capital(Or Share Stock) |
50,498,611,100.00 |
| Capital Surplus |
10,821,595,891.70 |
| Surplus Reserve |
5,740,430,152.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
42,525,162,365.50 |
| Minority Stockholder's Interest |
50,424,978,775.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
110,481,909,266.90 |
| Owner's Equity（Stockholder's Equity） |
160,906,888,042.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
412,691,535,075.45 |
